Spike RBD (B.1.351, Beta Variant) Avi-His-Tag (SARS-CoV-2) Recombinant

Only %1 left

Catalog #

100978

As low as $320 *

Cat # Size Price*

Qty

Bulk/Custom

Add to Favorites

*US Pricing only. For international pricing, please contact your local distributor.

●

Purchase

●

Description

Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.351, also know as variant Beta orignally discovered in South Africa and contains mutations K417N, E484K and N501Y. It also contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis). The recombinant protein was affinity purified.

●

Synonyms

20H/501Y.V2, South African Variant, South Africa coronavirus, SARS-CoV-2 S. African variant, beta variant

●

Product Data Gallery

4-20% SDS-Page Coomassie Staining

Spike RBD (B.1.351 Variant) (SARS-CoV-2) Activity

Product Info

Storage and Usage

Citations

Species

SARS-CoV-2

Construct

Spike RBD (B.1.351 Variant) (SARS-CoV-2) (319-541-Avi-His)

Mutation

K417N, E484K, N501Y

Host Species/Expression System

HEK293

Purity

≥90%

Supplied As

Aqueous buffer solution.

Formulation

8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol

28 kDa

Amino Acids

319-541

Glycosylation

This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Genbank #

MN908947

UniProt #

P0DTD1

Tag(s)

C-terminal Avi-His-Tag

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Spike RBD (B.1.351, Beta Variant) Avi-His-Tag (SARS-CoV-2) Recombinant

PRODUCTS

SERVICES

RESOURCES

COMPANY